Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma

Journal article

Open access

Peer reviewed

Sumita Khatri, Wendy Moore, Peter Gibson, Richard Leigh, Arnaud Bourdin, Jorge Maspero, Manuel Barros, Roland Buhl, Peter Howarth, Frank Albers, …

Journal of Allergy and Clinical Immunology

10/2018

Files and links (2)

url

Find in HALView

url

https://doi.org/10.1016/j.jaci.2018.09.033View

Published (Version of record) Open

1 Record Views

Title: Assessment of the long-term safety of mepolizumab and durability of clinical response in patients with severe eosinophilic asthma
Creators - without role: Sumita Khatri - Cleveland Clinic
Wendy Moore - Wake Forest University
Peter Gibson - University of Newcastle Australia
Richard Leigh - University of Calgary
Arnaud Bourdin - Université de Montpellier, Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExp
Jorge Maspero - Fundación Cidea Allergy and Respiratory Research Unit,
Manuel Barros - Hospital Carlos Van Buren
Roland Buhl - Mainz University
Peter Howarth - University of Southampton
Frank Albers - GlaxoSmithKline
Eric Bradford - GlaxoSmithKline
Martyn Gilson - Middlesex University
Robert Price - Age UK
Steven Yancey - GlaxoSmithKline
Hector Ortega - Torrey Pines Institute For Molecular Studies
Publication Details: Journal of Allergy and Clinical Immunology
Identifiers: 9944108409311
Academic Unit: Physiologie et Médecine Expérimentale du coeur et des muscles - PhyMedExp
Language: English
Resource Type: Journal article
Local Fields: hal-01906456